{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:38:53Z","timestamp":1791394733341,"version":"4.3.3"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P50DA036105"],"award-info":[{"award-number":["P50DA036105"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the U.S. Food and Drug Administration","award":["P30 DA033934"],"award-info":[{"award-number":["P30 DA033934"]}]},{"name":"the U.S. Food and Drug Administration","award":["DA 005274"],"award-info":[{"award-number":["DA 005274"]}]},{"name":"the U.S. Food and Drug Administration","award":["DA032246"],"award-info":[{"award-number":["DA032246"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.neuropharm.2019.107669","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T23:45:28Z","timestamp":1560815128000},"page":"107669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Assessing nicotine dependence using an oral nicotine free-choice paradigm in mice"],"prefix":"10.1016","volume":"157","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7353-0155","authenticated-orcid":false,"given":"Deniz","family":"Bagdas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare M.","family":"Diester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moriah","family":"Carper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Alkhlaif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7447-1353","authenticated-orcid":false,"given":"Dana","family":"AlOmari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"Alayoubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin L.","family":"Poklis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Imad","family":"Damaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2019.107669_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0166-4328(01)00448-X","article-title":"Restricted daily access to water and voluntary nicotine oral consumption in mice: methodological issues and individual differences","volume":"134","author":"Adriani","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107669_bib2","series-title":"Diagnostic and Statistical Manual of Mental Disorders\u202f: DSM-5","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.neuropharm.2019.107669_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0939-8600(00)80009-7","article-title":"Nicotine consumption of several mouse strains using a two bottle choice paradigm","volume":"40","author":"Aschhoff","year":"2000","journal-title":"J. Exp. Anim. Sci."},{"key":"10.1016\/j.neuropharm.2019.107669_bib4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neuropharm.2018.05.025","article-title":"New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in mice","volume":"138","author":"Bagdas","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.107669_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.pharmtox.48.113006.094742","article-title":"Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics","volume":"49","author":"Benowitz","year":"2009","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2019.107669_bib6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00210-010-0498-5","article-title":"Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats","volume":"381","author":"Biala","year":"2010","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107669_bib7","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/npp.2011.299","article-title":"Alpha7 nicotinic acetylcholine receptors modulate motivation to self-administer nicotine: implications for smoking and schizophrenia","volume":"37","author":"Brunzell","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl. 1","key":"10.1016\/j.neuropharm.2019.107669_bib8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neuropharm.2008.06.075","article-title":"Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis","volume":"56","author":"Carlezon","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.107669_bib9","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1523\/JNEUROSCI.22-04-01208.2002","article-title":"Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice","volume":"22","author":"Champtiaux","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107669_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2013.00041","article-title":"Animal models of nicotine exposure: relevance to second-hand smoking, electronic cigarette use, and compulsive smoking","volume":"4","author":"Cohen","year":"2013","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.107669_bib11","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1038\/npp.2012.67","article-title":"Robust escalation of nicotine intake with extended access to nicotine self-administration and intermittent periods of abstinence","volume":"37","author":"Cohen","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.107669_bib12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.pbb.2003.08.014","article-title":"Individual self-administration of nicotine by rats","volume":"76","author":"Dadmarz","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2019.107669_bib13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1124\/jpet.103.054908","article-title":"Characterization of spontaneous and precipitated nicotine withdrawal in the mouse","volume":"307","author":"Damaj","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2019.107669_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","article-title":"Tyrosine hydroxylase and regulation of dopamine synthesis","volume":"508","author":"Daubner","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neuropharm.2019.107669_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.alcohol.2012.12.004","article-title":"The \u03b22 nicotinic acetylcholine receptor subunit differentially influences ethanol behavioral effects in the mouse","volume":"47","author":"Dawson","year":"2013","journal-title":"Alcohol"},{"key":"10.1016\/j.neuropharm.2019.107669_bib16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s002130000497","article-title":"Nicotine selfadministration in rats: estrous cycle effects, sex differences and nicotinic receptor binding","volume":"151","author":"Donny","year":"2000","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2019.107669_bib17","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1471-4159.2004.02797.x","article-title":"Tyrosine hydroxylase phosphorylation: regulation and consequences","volume":"91","author":"Dunkley","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2019.107669_bib18","doi-asserted-by":"crossref","first-page":"7577","DOI":"10.1073\/pnas.1103000108","article-title":"Distinct contributions of nicotinic acetylcholine receptor subunit 4 and subunit 6 to the reinforcing effects of nicotine","volume":"108","author":"Exley","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2019.107669_bib19","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nature09797","article-title":"Habenular \u03b15 nicotinic receptor subunit signalling controls nicotine intake","volume":"471","author":"Fowler","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2019.107669_bib20","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00213-013-3235-1","article-title":"Role of \u03b15* nicotinic acetylcholine receptors in the effects of acute and chronic nicotine treatment on brain reward function in mice","volume":"229","author":"Fowler","year":"2013","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2019.107669_bib21","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00213-010-2024-3","article-title":"Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration","volume":"213","author":"George","year":"2011","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2019.107669_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/chemse\/bjn049","article-title":"Variation in nicotine consumption in inbred mice is not linked to orosensory ability","volume":"34","author":"Glatt","year":"2009","journal-title":"Chem. Senses"},{"key":"10.1016\/j.neuropharm.2019.107669_bib23","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1471-4159.1992.tb08322.x","article-title":"Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum","volume":"59","author":"Grady","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2019.107669_bib24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/gbb.12113","article-title":"Genetic variation within the Chrna7 gene modulates nicotine reward-like phenotypes in mice","volume":"13","author":"Harenza","year":"2014","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuropharm.2019.107669_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1124\/jpet.110.165738","article-title":"Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice","volume":"334","author":"Jackson","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2019.107669_bib26","first-page":"547","article-title":"The role of a6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal","volume":"331","author":"Jackson","year":"2009","journal-title":"J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107669_bib27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.neuropharm.2009.07.020","article-title":"Characterization of pharmacological and behavioral differences to nicotine in C57Bl\/6 and DBA\/2 mice","volume":"57","author":"Jackson","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.107669_bib28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.296.1.56","article-title":"Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial","volume":"296","author":"Jorenby","year":"2006","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.neuropharm.2019.107669_bib29","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1038\/npp.2016.32","article-title":"Diversity of dopaminergic neural circuits in response to drug exposure","volume":"41","author":"Juarez","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.107669_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pbb.2004.01.005","article-title":"Sex differences in voluntary oral nicotine consumption by adolescent mice: a dose-response experiment","volume":"78","author":"Klein","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2019.107669_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbr.2008.08.048","article-title":"Nicotinic \u03b17- or \u03b22-containing receptor knockout: effects on radial-arm maze learning and long-term nicotine consumption in mice","volume":"196","author":"Levin","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107669_bib32","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.neuropharm.2012.04.037","article-title":"Adult mice voluntarily progress to nicotine dependence in an oral self-selection assay","volume":"63","author":"Locklear","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.107669_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature03694","article-title":"Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors","volume":"436","author":"Maskos","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2019.107669_bib34","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0091-3057(94)00354-8","article-title":"Ethanol, nicotine, amphetamine, and aspartame consumption and preferences in C57BL\/6 and DBA\/2 mice","volume":"50","author":"Meliska","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2019.107669_bib35","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.2174\/138161211795656747","article-title":"Animal models of addiction: fat and sugar","volume":"17","author":"Morgan","year":"2011","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.neuropharm.2019.107669_bib36","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s10519-013-9605-y","article-title":"Nine generations of selection for high and low nicotine intake in outbred Sprague-Dawley rats","volume":"43","author":"Nesil","year":"2013","journal-title":"Behav. Genet."},{"key":"10.1016\/j.neuropharm.2019.107669_bib37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pbb.2015.02.009","article-title":"Nicotine withdrawal in selectively bred high and low nicotine preferring rat lines","volume":"131","author":"Nesil","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2019.107669_bib38","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.neuropharm.2016.06.023","article-title":"Voluntary co-consumption of alcohol and nicotine: effects of abstinence, intermittency, and withdrawal in mice","volume":"109","author":"O'Rourke","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.107669_bib39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0165-0173(87)90011-7","article-title":"Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity","volume":"434","author":"Oades","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107669_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0182142","article-title":"Altered nicotine reward-associated behavior following \u03b14 nAChR subunit deletion in ventral midbrain","volume":"12","author":"Peng","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2019.107669_bib41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/34413","article-title":"Acetylcholine receptors containing the \u03b22 subunit are involved in the reinforcing properties of nicotine","volume":"391","author":"Picciotto","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2019.107669_bib42","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/jnr.23858","article-title":"Sex differences in nicotine preference","volume":"95","author":"Pogun","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2019.107669_bib43","doi-asserted-by":"crossref","first-page":"12318","DOI":"10.1523\/JNEUROSCI.3918-08.2008","article-title":"Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration","volume":"28","author":"Pons","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107669_bib44","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2105\/AJPH.2012.301070","article-title":"Alternative tobacco product use and smoking cessation: a national study","volume":"103","author":"Popova","year":"2013","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.neuropharm.2019.107669_bib45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1471-2202-15-89","article-title":"Chronic nicotine pretreatment is sufficient to upregulate alpha4* nicotinic receptors and increase oral nicotine self-administration in mice","volume":"15","author":"Renda","year":"2014","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107669_bib46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuropharm.2016.04.019","article-title":"Vulnerability to nicotine self-administration in adolescent mice correlates with age-specific expression of alpha4* nicotinic receptors","volume":"108","author":"Renda","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.107669_bib47","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.neuroscience.2008.04.020","article-title":"Neonatal 6-hydroxydopamine lesions of the frontal cortex in rats: persisting effects on locomotor activity, learning and nicotine self-administration","volume":"154","author":"Rezvani","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2019.107669_bib48","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/BF02247438","article-title":"Inbred mouse strains vary in oral self-selection of nicotine","volume":"124","author":"Robinson","year":"1996","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2019.107669_bib49","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/00006842-196607000-00028","article-title":"Factors underlying differences in alcohol preference among inbred strains of mice","volume":"28","author":"Rodgers","year":"1966","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.neuropharm.2019.107669_bib50","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.neuropharm.2006.10.016","article-title":"Pharmacological profile of the \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid","volume":"52","author":"Rollema","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.107669_bib51","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4278\/ajhp.120926-QUAN-469","article-title":"Impact of promotions on awareness, trial, and likelihood of trial of new dissolvable tobacco","volume":"28","author":"Romito","year":"2014","journal-title":"Am. J. Health Promot."},{"key":"10.1016\/j.neuropharm.2019.107669_bib52","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0160-5402(83)90064-5","article-title":"Oral administration of nicotine: its uptake and distribution after chronic administration to mice","volume":"9","author":"Rowell","year":"1983","journal-title":"J. Pharmacol. Methods"},{"key":"10.1016\/j.neuropharm.2019.107669_bib53","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1124\/mol.63.5.1059","article-title":"The nicotinic acetylcholine receptor subunit alpha 5 mediates short-term effects of nicotine in vivo","volume":"63","author":"Salas","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107669_bib54","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejphar.2008.06.081","article-title":"Effect of forced chronic oral nicotine exposure on intravenous self-administration and rewarding properties of acute nicotine","volume":"591","author":"Tammim\u00e4ki","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107669_bib55","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.296.1.64","article-title":"Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial","volume":"296","author":"Tonstad","year":"2006","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.neuropharm.2019.107669_bib56","doi-asserted-by":"crossref","first-page":"7563","DOI":"10.1523\/JNEUROSCI.0069-12.2012","article-title":"Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats","volume":"32","author":"Vendruscolo","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107669_bib57","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00213-005-0295-x","article-title":"The \u03b22 but not \u03b17 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice","volume":"184","author":"Walters","year":"2006","journal-title":"Psychopharmacology (Berlin)"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819302291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819302291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T20:45:31Z","timestamp":1569185131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390819302291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":57,"alternative-id":["S0028390819302291"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107669","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing nicotine dependence using an oral nicotine free-choice paradigm in mice","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107669","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107669"}}